<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.diabesityrounds.com/a/ada-2026-obesity-criteria-raise-prevalence-across-45-population-surveys</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-06T20:02:14.236Z</news:publication_date><news:title>ADA 2026 obesity criteria raise prevalence across 45 population surveys</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/semaglutide-and-hba1c-weight-and-bp-across-ckd-stages-in-flow-post-hoc-analysis</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-04T20:32:59.680Z</news:publication_date><news:title>Semaglutide and HbA1c, weight and BP across CKD stages in FLOW post hoc analysis</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/weight-loss-not-significantly-linked-to-incretin-heart-benefit-in-meta-regressio</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-04T20:17:09.490Z</news:publication_date><news:title>Weight loss not significantly linked to incretin heart benefit in meta-regression</news:title></news:news></url></urlset>